These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16075304)

  • 21. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
    Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
    Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
    Sindhu T; Srinivasan P
    J Recept Signal Transduct Res; 2014 Aug; 34(4):241-53. PubMed ID: 25072161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of N-phenyl-(2-aminothiazol-4-yl)acetamides with phenoxypropanolamine moiety as selective β3-adrenergic receptor agonists.
    Maruyama T; Onda K; Suzuki T; Hayakawa M; Takahashi T; Matsui T; Takasu T; Nagase I; Ohta M
    Chem Pharm Bull (Tokyo); 2012; 60(5):647-58. PubMed ID: 22689403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
    Halder AK; Saha A; Saha KD; Jha T
    J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling and informatics in designing anti-diabetic agents.
    Bharatam PV; Patel DS; Adane L; Mittal A; Sundriyal S
    Curr Pharm Des; 2007; 13(34):3518-30. PubMed ID: 18220788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive quantitative structure-activity relationships (QSAR) analysis of beta 3-adrenergic ligands.
    Blin N; Federici C; Koscielniak T; Strosberg AD
    Drug Des Discov; 1995 Apr; 12(4):297-311. PubMed ID: 9040990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
    Sharma MC
    Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel substituted 4-aminomethylpiperidines as potent and selective human beta3-agonists. Part 1: aryloxypropanolaminomethylpiperidines.
    Steffan RJ; Ashwell MA; Solvibile WR; Matelan E; Largis E; Han S; Tillet J; Mulvey R
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2957-61. PubMed ID: 12270183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of nitric oxide in beta3-adrenoceptor activation on basal tone of internal anal sphincter.
    Banwait KS; Rattan S
    Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G547-55. PubMed ID: 12736154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors.
    Reddy KK; Singh SK; Dessalew N; Tripathi SK; Selvaraj C
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):339-47. PubMed ID: 21699459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QSAR studies on 3-(4-biphenylmethyl) 4, 5-dihydro-4-oxo-3H-imidazo [4, 5-c] Pyridine derivatives as angiotensin II (AT1) receptor antagonist.
    Sharma MC
    Interdiscip Sci; 2015 Jun; 7(2):113-28. PubMed ID: 26215494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-model in silico characterization of 3-benzamidobenzoic acid derivatives as partial agonists of Farnesoid X receptor in the management of NAFLD.
    Mitra S; Halder AK; Ghosh N; Mandal SC; Cordeiro MNDS
    Comput Biol Med; 2023 May; 157():106789. PubMed ID: 36963353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward the identification of a reliable 3D QSAR pharmacophore model for the CCK2 receptor antagonism.
    Gupta AK; Varshney K; Saxena AK
    J Chem Inf Model; 2012 May; 52(5):1376-90. PubMed ID: 22530718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into the binding modes of human β₃-adrenergic receptor agonists with ligand-based and receptor-based methods.
    Jin F; Lu C; Sun X; Li W; Liu G; Tang Y
    Mol Divers; 2011 Nov; 15(4):817-31. PubMed ID: 21424594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substituted 1,2,3,4-tetrahydroquinolin-6-yloxypropanes as beta3-adrenergic receptor agonists: design, synthesis, biological evaluation and pharmacophore modeling.
    Shakya N; Roy KK; Saxena AK
    Bioorg Med Chem; 2009 Jan; 17(2):830-47. PubMed ID: 19081260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacophore Modelling and 3D-QSAR Studies on N(3)-Phenylpyrazinones as Corticotropin-Releasing Factor 1 Receptor Antagonists.
    Kaur P; Sharma V; Kumar V
    Int J Med Chem; 2012; 2012():452325. PubMed ID: 25984369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacophore modeling, 3D-QSAR and DFT studies of IWR small-molecule inhibitors of Wnt response.
    Kirubakaran P; Karthikeyan M
    J Recept Signal Transduct Res; 2013 Oct; 33(5):276-85. PubMed ID: 23914783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2D-QSAR and 3D-QSAR/CoMSIA Studies on a Series of (R)-2-((2-(1H-Indol-2-yl)ethyl)amino)-1-Phenylethan-1-ol with Human β₃-Adrenergic Activity.
    Apablaza G; Montoya L; Morales-Verdejo C; Mellado M; Cuellar M; Lagos CF; Soto-Delgado J; Chung H; Pessoa-Mahana CD; Mella J
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28273884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacophore modeling, comprehensive 3D-QSAR, and binding mode analysis of TGR5 agonists.
    Sindhu T; Srinivasan P
    J Recept Signal Transduct Res; 2017 Apr; 37(2):109-123. PubMed ID: 27267434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.